Kevin M Elias Selected Research

Carcinoma (Carcinomatosis)

1/2022	DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.
10/2021	Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer.
12/2018	Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors.
1/2016	Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer.
5/2010	Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kevin M Elias Research Topics

Disease

30	Neoplasms (Cancer) 01/2024 - 01/2007
29	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 02/2023 - 05/2010
21	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 02/2014
10	Hydatidiform Mole (Molar Pregnancy) 11/2021 - 11/2015
9	Ovarian Epithelial Carcinoma 01/2023 - 01/2007
6	Choriocarcinoma 01/2021 - 07/2011
5	Carcinoma (Carcinomatosis) 01/2022 - 05/2010
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
3	Disease Progression 11/2019 - 05/2010
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 01/2017
2	Endometriosis 01/2024 - 01/2016
2	Ascites 08/2023 - 01/2022
2	Adenocarcinoma 12/2018 - 08/2015
1	Circulating Neoplastic Cells 08/2023
1	COVID-19 01/2023
1	Hemorrhage 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Cysts 01/2022
1	Postoperative Nausea and Vomiting (PONV) 01/2022
1	Hyperthyroidism 01/2022
1	Stillbirth 01/2022
1	Spontaneous Abortion (Miscarriage) 01/2022
1	Uterine Hemorrhage (Uterine Bleeding) 01/2021
1	Venous Thromboembolism 01/2021
1	Neutropenia 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2019
1	Anemia 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Febrile Neutropenia 01/2019
1	Vomiting 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2018
1	Uterine Perforation 04/2018

Drug/Important Bio-Agent (IBA)

12	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2023 - 11/2015
10	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2007
9	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2016
8	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 01/2017
7	PlatinumIBA 11/2022 - 01/2016
5	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 06/2022 - 02/2014
3	Tumor Biomarkers (Tumor Markers)IBA 02/2023 - 01/2019
3	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2023 - 01/2019
3	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2021 - 01/2016
3	Leucovorin (Folinic Acid)FDA Link 01/2021 - 01/2019
3	Anesthetics (Anesthetic Agents)IBA 12/2015 - 04/2015
2	CA-125 Antigen (CA 125 Antigen)IBA 02/2022 - 01/2022
2	ParaffinIBA 01/2021 - 07/2011
2	Transcription Factors (Transcription Factor)IBA 08/2016 - 06/2014
1	Immunoconjugates (Immunoconjugate)IBA 04/2024
1	Hormones (Hormone)IBA 01/2024
1	Chemokine CCL5IBA 08/2023
1	Epithelial Cell Adhesion MoleculeIBA 08/2023
1	Interleukin-6 (Interleukin 6)IBA 08/2023
1	CytokinesIBA 08/2023
1	pembrolizumabIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	Morphine (MS Contin)FDA LinkGeneric 01/2022
1	LuteinIBA 01/2022
1	MMEIBA 01/2022
1	Iodide Peroxidase (Deiodinase)IBA 11/2021
1	Selenoproteins (Selenoprotein)IBA 11/2021
1	Local AnestheticsIBA 10/2021
1	Voltage-Gated Sodium ChannelsIBA 10/2021
1	Ion Channels (Ion Channel)IBA 10/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Growth Differentiation Factor 2IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	AntioxidantsIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	VitaminsIBA 01/2020
1	Doxycycline (Periostat)FDA LinkGeneric 11/2019
1	Cisplatin (Platino)FDA LinkGeneric 05/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Indicators and Reagents (Reagents)IBA 04/2018
1	EndoglinIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 02/2023 - 05/2012
12	Therapeutics 11/2022 - 01/2007
6	Cytoreduction Surgical Procedures 01/2021 - 04/2015
3	Immunotherapy 08/2023 - 01/2022
3	Curettage 11/2019 - 05/2010
2	Enhanced Recovery After Surgery 01/2021 - 01/2021
1	Secondary Prevention 04/2024
1	Neoadjuvant Therapy 01/2023
1	Carbohydrate Loading Diet 01/2023
1	Anesthesia 01/2022
1	Treatment Delay 01/2020
1	Hysterectomy 11/2019
1	Aftercare (After-Treatment) 11/2019
1	Brachytherapy 01/2019
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 09/2018
1	Salpingectomy 09/2018
1	Ovariectomy (Oophorectomy) 09/2018
1	Length of Stay 01/2018